Left Thalamus Arteriovenous Malformation Secondary to Radiation Therapy of Original Vermian Arteriovenous Malformation: Case Report.


Journal

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
ISSN: 1532-8511
Titre abrégé: J Stroke Cerebrovasc Dis
Pays: United States
ID NLM: 9111633

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 19 01 2019
revised: 04 03 2019
accepted: 13 03 2019
pubmed: 13 4 2019
medline: 14 6 2019
entrez: 13 4 2019
Statut: ppublish

Résumé

A 70-year-old gentleman with history of hypothyroidism, hyperlipidemia, hypertension, and right superior cerebellar aneurysm presented to the neurosurgery service in 2008 with vertigo. Diagnostic cerebral angiography performed that year demonstrated a vermian arteriovenous malformations (AVM). The patient underwent stereotactic proton beam radiosurgery, which resulted in a decrease in flow and size of the lesion, and the patient was lost to follow-up. Now at the age of 80, the patient presented with acute gait instability. Cerebral angiogram demonstrated his stable vermian AVM and a new 1.1 cm AVM nidus in the region of the left posterior thalamus. Although AVMs are often described as congenital lesions, there is a growing body of literature suggesting that AVMs can grow, spontaneously regress, and even arise de novo in response to some insult. Understanding what leads to the growth, remodeling, regression, and hemorrhage of AVMs is crucial in order to better direct therapeutic endeavors. We would argue that this patient's AVM is secondary to endothelial cell damage from radiation therapy. Radiation can cause endothelial cell injury and upregulation of factors, such as vascular endothelial growth factor and transforming growth factor beta expression, which are implicated in AVM development pathways. We believe that this patient's new AVM is secondary to entrance radiation dosing affecting the thalamus during radiation therapy for the original vermian AVM.

Identifiants

pubmed: 30975463
pii: S1052-3057(19)30128-4
doi: 10.1016/j.jstrokecerebrovasdis.2019.03.033
pii:
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e53-e59

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Carlos Torres-Quinones (C)

Department of Neurosurgery, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: carlos_torres@hms.harvard.edu.

Matthew J Koch (MJ)

Department of Neurosurgery, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: mjkoch@partners.org.

Scott B Raymond (SB)

Department of Neurosurgery, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: scott.raymond@mgh.harvard.edu.

Aman Patel (A)

Department of Neurosurgery, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: abpatel@mgh.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH